RxDoctor Payments Data

Morganna Freeman

Medical Oncology · Glendale, CANPI 1730314345

Payments from drug & device makers

$285,235in general payments, 2019–2025

Across 199 payments — averaging $1433.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Merck$77K
  • Regeneron Healthcare Solutions, Inc.$71K
  • E.r. Squibb & Sons, L.L.C.$49K
  • Sanofi$46K
  • Regeneron$22K
  • Novartis$19K
  • plus $850 from 2 others
$18,934in research payments, 2019–2025

Across 19 payments — averaging $996.54 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Amgen$14K
  • Regeneron$5K

What the payments were for

  • Consulting fees$62,80625%
  • Speaking & faculty fees$146,83559%
  • Travel & lodging$37,53915%
  • Food & beverage$2,6091%
  • Education$800%

General payments by program year

19
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$285,235 in reported general payments places this provider in the 65th percentile of 379 medical oncology providers in California.

See all medical oncology providers in California

Other medical oncology in Glendale

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →